š”š²šš š¦ššŗšŗš®šæš
ā¢ Lupin Limited has entered into a strategic partnership with Amman Pharmaceuticals Industries to exclusively market and commercialize Ranibizumab biosimilar in the Middle East and select territories.
ā¢ The drug is used to treat various age-related eye conditions and Lupin aims to expand patient access to innovative healthcare solutions in the MENA region.
ā¢ Lupin reported a 3.77 fold year-on-year rise in consolidated net profit for the July-September quarter and a 40.4 percent increase in North America sales.